Saksela O, Laiho M, Keski-Oja J
Cancer Res. 1985 May;45(5):2314-9.
Low-molecular-weight protein factors (Mr 8,000 to 18,000) from serum-free conditioned medium of human fibrosarcoma (8387) cells reversibly enhanced the secretion of proteinase-inhibitory activity by cultured normal human skin fibroblasts. This inhibitory activity could be absorbed by immobilized plasminogen activator (PA) of urokinase type but not by heparin, and it was sensitive to treatment with sodium dodecyl sulfate. The secretion of a heparin-binding Mr 60,000 proteinase inhibitor, resembling protease nexin, was also detected. Early passages of adult skin fibroblasts do not contain or secrete PA. When cell types secreting this enzyme were tested, the fibrosarcoma-derived factors decreased the PA secretion detectable after sodium dodecyl sulfate treatment in all conditioned media of normal and malignant fibroblastic cells examined, including the 8387 cell line itself. However, no effects on the secretion of PA by normal or malignant cells of epithelioid origin or by melanoma cells were seen. A similar preparation from human epidermoid carcinoma (A431)-conditioned medium did not affect the PA activity or secretion of proteinase inhibitors from fibroblastic cells. The ability of sarcoma cells to modulate the production of PA inhibitors is a novel characteristic in the regulation of cellular proteolysis.
来自人纤维肉瘤(8387)细胞无血清条件培养基的低分子量蛋白质因子(分子量8,000至18,000)可逆地增强了培养的正常人皮肤成纤维细胞的蛋白酶抑制活性分泌。这种抑制活性可被固定化的尿激酶型纤溶酶原激活剂(PA)吸收,但不能被肝素吸收,并且它对十二烷基硫酸钠处理敏感。还检测到一种类似于蛋白酶连接蛋白的肝素结合性分子量60,000蛋白酶抑制剂的分泌。成人皮肤成纤维细胞的早期传代不含有或分泌PA。当测试分泌这种酶的细胞类型时,在所有检测的正常和恶性成纤维细胞(包括8387细胞系本身)的条件培养基中,纤维肉瘤衍生因子降低了十二烷基硫酸钠处理后可检测到的PA分泌。然而,未观察到对上皮样来源的正常或恶性细胞或黑素瘤细胞的PA分泌有影响。来自人表皮样癌(A431)条件培养基的类似制剂不影响成纤维细胞的PA活性或蛋白酶抑制剂的分泌。肉瘤细胞调节PA抑制剂产生的能力是细胞蛋白水解调节中的一个新特征。